Fragmentation in US health care delivery streams and shortcomings in formal quality measures mean that transparency could be more useful to policymakers and regulators than patients.
AMA J Ethics. 2022;24(11):E1075-1082. doi:
10.1001/amajethics.2022.1075.
Sarosh Nagar, Leah Z. Rand, PhD, and Aaron S. Kesselheim, MD, JD, MPH
This article analyzes differences in prescription drug pricing transparency practices among 3 Organisation of Economic Co-operation and Development member nations.
AMA J Ethics. 2022;24(11):E1083-1090. doi:
10.1001/amajethics.2022.1083.
Most physicians schedule out months in advance, requiring their patients to cope with their condition until their appointment and risk their suffering becoming discredited.
AMA J Ethics. 2022;24(12):E1181-1182. doi:
10.1001/amajethics.2022.1181.
Dr Amy Collins joins Ethics Talk to discuss her article, coauthored with Dr Shanda Demorest: “How Should We Respond to Health Care Generating Environmental Harm?”
Dumping domestic and international health care waste into the earth’s terra firma and oceans undermine global health equity and the health of vulnerable communities.
AMA J Ethics. 2022;24(10):E986-993. doi:
10.1001/amajethics.2022.986.
Dr Jing Li joins Ethics Talk to discuss her article, coauthored with Dr Robert Tyler Braun, Sophia Kakarala, and Dr Holly G. Prigerson: “How Should Cost-Informed Goals of Care Decisions Be Facilitated at Life’s End?”
Dr Mustfa K. Manzur joins Ethics Talk to discuss his article, coauthored with Drs Sharon Griswold and Wendy Dean: "What Should Clinicians Do When Health Services Are Improperly Billed in Their Names?"
Dr Christopher Whaley joins Ethics Talk to discuss his article, coauthored with Dr Austin Frakt: “If Patients Don’t Use Available Health Service Pricing Information, Is Transparency Still Important?”